-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CpSMxdTFb8fC1JNJ8kqlNvYQ6qrG3TUwGxSwH7cR+0Le2dyDLylfzVGriQrBcT9V 9X7yxakai7CDwTTRPbCJYQ== 0001144204-10-029117.txt : 20100519 0001144204-10-029117.hdr.sgml : 20100519 20100519202940 ACCESSION NUMBER: 0001144204-10-029117 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100517 FILED AS OF DATE: 20100519 DATE AS OF CHANGE: 20100519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMATHENE, INC CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 BUSINESS PHONE: 410 269 2600 MAIL ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHAFFER DERACE L CENTRAL INDEX KEY: 0001031735 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 10846514 MAIL ADDRESS: STREET 1: C/O ALLION HEALTHCARE, INC. STREET 2: 1660 WALT WHITMAN ROAD, SUITE 105 CITY: MELVILLE STATE: NY ZIP: 11747 4 1 v185967_ex.xml X0303 4 2010-05-17 0 0001326190 PHARMATHENE, INC PIP 0001031735 SCHAFFER DERACE L C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 1 0 0 0 Common Stock, $0.0001 par value per share 2010-05-17 4 P 0 16747 1.4206 A 757911 D Common Stock, $0.0001 par value per share 2010-05-18 4 P 0 83253 1.4981 A 841164 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.45, inclusive. The reporting person undertakes to provide to PharmAthene, Inc., any security holder of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.50, inclusive. /s/ Roland S. Chase, attorney in fact 2010-05-17 -----END PRIVACY-ENHANCED MESSAGE-----